[go: up one dir, main page]

CN115836077A - 氧杂氮杂螺环类衍生物、其制备方法及其在医药上的应用 - Google Patents

氧杂氮杂螺环类衍生物、其制备方法及其在医药上的应用 Download PDF

Info

Publication number
CN115836077A
CN115836077A CN202180046644.2A CN202180046644A CN115836077A CN 115836077 A CN115836077 A CN 115836077A CN 202180046644 A CN202180046644 A CN 202180046644A CN 115836077 A CN115836077 A CN 115836077A
Authority
CN
China
Prior art keywords
group
alkyl
cancer
groups
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202180046644.2A
Other languages
English (en)
Other versions
CN115836077B (zh
Inventor
陆标
张蔡华
贺峰
陶维康
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Hengrui Medicine Co Ltd
Shanghai Hengrui Pharmaceutical Co Ltd
Original Assignee
Jiangsu Hengrui Medicine Co Ltd
Shanghai Hengrui Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hengrui Medicine Co Ltd, Shanghai Hengrui Pharmaceutical Co Ltd filed Critical Jiangsu Hengrui Medicine Co Ltd
Publication of CN115836077A publication Critical patent/CN115836077A/zh
Application granted granted Critical
Publication of CN115836077B publication Critical patent/CN115836077B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

公开了一种氧杂氮杂螺环类衍生物、其制备方法及其在医药上的应用。具体而言，公开了一种通式(I)所示的氧杂氮杂螺环类衍生物、其制备方法及含有该衍生物的药物组合物以及其作为治疗剂的用途，特别是作为PI3Kδ抑制剂的用途和在制备用于治疗通过对PI3Kδ的抑制而改善的疾病或病症的药物中的用途。

Description

PCT国内申请，说明书已公开。

Claims (17)

  1. PCT国内申请，权利要求书已公开。
CN202180046644.2A 2020-07-29 2021-07-29 氧杂氮杂螺环类衍生物、其制备方法及其在医药上的应用 Active CN115836077B (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CN202010746651 2020-07-29
CN2020107466510 2020-07-29
CN202010954059X 2020-09-11
CN202010954059 2020-09-11
CN2021102102033 2021-02-24
CN202110210203 2021-02-24
PCT/CN2021/109205 WO2022022630A1 (zh) 2020-07-29 2021-07-29 氧杂氮杂螺环类衍生物、其制备方法及其在医药上的应用

Publications (2)

Publication Number Publication Date
CN115836077A true CN115836077A (zh) 2023-03-21
CN115836077B CN115836077B (zh) 2025-05-13

Family

ID=80037656

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180046644.2A Active CN115836077B (zh) 2020-07-29 2021-07-29 氧杂氮杂螺环类衍生物、其制备方法及其在医药上的应用

Country Status (7)

Country Link
US (1) US20230234962A1 (zh)
EP (1) EP4190789A1 (zh)
JP (1) JP2023536442A (zh)
CN (1) CN115836077B (zh)
CA (1) CA3186193A1 (zh)
TW (1) TW202214656A (zh)
WO (1) WO2022022630A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118852506A (zh) * 2024-06-25 2024-10-29 华东理工大学 三线态能量转移诱导聚合光催化剂及其制备方法和应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060128685A1 (en) * 2003-02-07 2006-06-15 Daiichi Pharmaceutical Co., Ltd., Pyrazole derivative
CN102695710A (zh) * 2009-11-13 2012-09-26 默克雪兰诺有限公司 三环吡唑胺衍生物
WO2014121901A1 (en) * 2013-02-07 2014-08-14 Merck Patent Gmbh Polymorphic forms
WO2015196335A1 (en) * 2014-06-23 2015-12-30 Tocopherx, Inc. Pyrazole compounds as modulators of fshr and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010503656A (ja) 2006-09-13 2010-02-04 アストラゼネカ アクチボラグ スピロ−オキサゾリジノン化合物と代謝共役型グルタミン酸受容体ポテンシエーターとしてのその使用
EP3013832B1 (en) 2013-06-24 2020-11-04 Merck Patent GmbH Pyrazole compounds as modulators of fshr and uses thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060128685A1 (en) * 2003-02-07 2006-06-15 Daiichi Pharmaceutical Co., Ltd., Pyrazole derivative
CN102695710A (zh) * 2009-11-13 2012-09-26 默克雪兰诺有限公司 三环吡唑胺衍生物
WO2014121901A1 (en) * 2013-02-07 2014-08-14 Merck Patent Gmbh Polymorphic forms
WO2015196335A1 (en) * 2014-06-23 2015-12-30 Tocopherx, Inc. Pyrazole compounds as modulators of fshr and uses thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118852506A (zh) * 2024-06-25 2024-10-29 华东理工大学 三线态能量转移诱导聚合光催化剂及其制备方法和应用

Also Published As

Publication number Publication date
TW202214656A (zh) 2022-04-16
EP4190789A1 (en) 2023-06-07
CA3186193A1 (en) 2022-02-03
JP2023536442A (ja) 2023-08-25
US20230234962A1 (en) 2023-07-27
WO2022022630A1 (zh) 2022-02-03
CN115836077B (zh) 2025-05-13

Similar Documents

Publication Publication Date Title
CN107548391A (zh) 嘧啶或吡啶类化合物、其制备方法和医药用途
CN110573500A (zh) N-(氮杂芳基)环内酰胺-1-甲酰胺衍生物及其制备方法和应用
CN106660974A (zh) 含氨磺酰基的1,2,5‑噁二唑类衍生物、其制备方法及其在医药上的应用
RU2018119173A (ru) Производное бензофурана, способ его получения и его применение в медицине
JP2018515438A5 (zh)
JP2018507877A5 (zh)
JP2008528467A5 (zh)
RU2014121074A (ru) Соединения 8-фторфталазин-1(2н)-она в качестве ингибиторов тирозинкиназы брутона
JP2014518544A5 (zh)
RU2018129308A (ru) Новые производные аммония, способ их получения и фармацевтические композиции, содержащие их
JP2017509689A5 (zh)
JP2020066629A5 (zh)
RU2016118753A (ru) Производные пиридилкетона, способ их получения и их фармацевтическое применение
CN111989332A (zh) 作为cdk抑制剂的大环化合物、其制备方法及其在医药上的应用
RU2015143717A (ru) 2-Аминопиримидин-6-оны и аналоги, проявляющие противораковые и антипролиферативные действия
JP2020504716A5 (zh)
JP2016513660A5 (zh)
CN111601797A (zh) 苯并哌啶或杂芳基并哌啶类衍生物、其制备方法及其在医药上的应用
JP2013533883A5 (zh)
MY189345A (en) Heteroaryl derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition for preventing or treating diseases associated with pi3 kinases, containing same as active ingredient
RU2017136715A (ru) Производное имидазоизоиндола, способ его получения и медицинское применение
JP2016537382A5 (zh)
MX2016014574A (es) El uso de compuestos de tienotriazolodiazepina para el tratamiento de cancer de mama triple-negativo.
JP2023164918A5 (zh)
CN114746424A (zh) 三环四氢异喹啉类衍生物、其制备方法及其在医药上的应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant